Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7%, but ...

Teladoc witnessed a price rise after Citron Research highlighted strong growth prospects following the company’s Goldman Sachs presentation, where management revealed that embedding BetterHelp ...

Teladoc Health (NYSE: TDOC) is scheduled to announce Q2 results on Tuesday, July 29th, after market close, and investor focus will be on the details behind usual numbers—especially segment trends, ...

Live Updates Live Coverage Has Ended 'Under-the-Radar' AI Play 2:57 pm by Gerelyn Terzo Citron Research has come out touting Teladoc Health (Nasdaq: TDOC) as an “under-the-radar” AI stock ...

Teladoc research shows AI-powered 'nudges' can improve diabetes members' engagement, health outcomes By Heather Landi Jun 24, 2024 8:10am ...

The results come on the heels of previous research that demonstrated Teladoc Health’s ability to proactively identify a person at-risk for uncontrolled outcomes more than a year in advance using AI.